EUVIMEDEUVIMED entdecken
Open Access

Oral co-administration of Lactiplantibacillus plantarum 16 and Lacticaseibacillus rhamnosus P118 improves host defense against influenza A virus infection

Meiqing Han, Qi Lu iD, Di Wang, Kun Zhou, Chenghao Jia, Lin Teng, Azeguli Hamuti, Xianqi Peng, Yixiang Hu, Weifen Li, Min Yue iD, Yan Li iD

Journal of Virology · 22.10.2024 · 98 (10)

DOI: 10.1128/jvi.00950-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, erschienen am 22.10.2024. Verfasst von Meiqing Han und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medicine and Institute of Preventive Veterinary Sciences, Zhejiang University College of Animal Sciences, Hangzhou, Zhejiang…. Hauptthemen laut MEDLINE: Probiotics, Lacticaseibacillus rhamnosus, Orthomyxoviridae Infections, Mice, Inbred BALB C. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | NSFC | NSFC-Zhejiang Joint Fund | | Natural Science Foundation of Zhejiang Province (ZJNSF), MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Influenza is an important zoonotic disease that persistently threatens global public health. While it is widely acknowledged that probiotics can modulate the host response to protect the host against infectious disease, the prophylactic efficacy on respiratory viral infection and the detailed mechanism remains elusive. Lactobacillus , the most commonly used probiotic widely applied in food production, has garnered significant attention. In our study utilizing both C57BL/6 and BALB/c mouse models, we explored the protective effect against two strains of influenza virus, A/Mink/China/01/2014(H9N2) and A/California/04/2009(H1N1), through the administration of Lactiplantibacillus plantarum strain 16 ( L. plantarum 16) and Lacticaseibacillus rhamnosus strain P118 ( L. rhamnosus P118), aiming to identify robust probiotic strains with antiviral properties. Our findings indicate that administering L. plantarum 16 or L. rhamnosus P118 alone does not provide sufficient protection against influenza. However, the co-administration of L. plantarum 16 and L. rhamnosus P118 dramatically reduces viral titers in the respiratory tract and lung, thereby markedly alleviating the clinical symptoms, improving prognosis, and reducing mortality. The mechanisms underlying this effect involve the modulation of host gut microbiota and metabolism through the co-administration of L. plantarum 16 and L. rhamnosus P118, resulting in enrichment of Firmicutes and enhancement of phenylalanine-related metabolism, ultimately leading to an augmentation of the antiviral immune response. Notably, we identified that the circulating metabolic molecule 2-Hydroxycinnamic acid plays a significant role in combating influenza. Our data suggest the potential utility of L. plantarum 16 and L. rhamnosus P118 two-bacterium or 2-Hydroxycinnamic acid in preventing influenza. IMPORTANCE Vaccination represents the most optimal strategy to control influenza. Nevertheless, influenza viruses constantly evolve due to antigenic drift and shift, leading to the need for regular updates on influenza vaccines. Additionally, vaccination failure poses significant challenges to influenza prevention. Therefore, it is essential and beneficial to identify novel or universal antiviral measures to protect against influenza. While cumulative data suggest that probiotics offer protection against infectious diseases, the specific mechanisms, such as the effective metabolites or components, remain largely unknown. Our research discovered the capacity of combinational two-bacterium Lactiplantibacillus plantarum 16 and Lacticaseibacillus rhamnosus P118 to fight against influenza infection in a mouse model. The protection may occur through modulating the host’s gut microbiota and metabolism, further influencing the host’s antiviral immune response. Notably, we have identified a novel metabolic molecule, 2-Hydroxycinnamic acid, capable of enhancing antiviral response and restricting viral replication in vivo .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsLacticaseibacillus rhamnosusOrthomyxoviridae InfectionsMice, Inbred BALB CMice, Inbred C57BLAnimalsMiceLactiplantibacillus plantarumAdministration, OralFemaleInfluenza A Virus, H1N1 SubtypeInfluenza A virusLung

Stichwörter der Autor:innen

2-Hydroxycinnamic acidL. plantarumL. rhamnosusgut microbiomeinfluenza A virusmetaboliteprobiotics

Autor:innen und Institutionen

  • Department of Veterinary Medicine and Institute of Preventive Veterinary Sciences, Zhejiang University College of Animal Sciences, Hangzhou, Zhejiang, China.
  • Hainan Institute of Zhejiang University, Sanya, Hainan, China.
  • MOA Key Laboratory of Animal Virology, Zhejiang Provincial Key Laboratory of Preventive Veterinary Medicine, Hangzhou, Zhejiang, China.
  • Key Laboratory of Molecular Animal Nutrition, Ministry of Education, Key Laboratory of Animal Feed and Nutrition of Zhejiang Province, Institute of Feed Science, Zhejiang University College of Animal Sciences, Hangzhou,…
  • State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, The First Affiliated Hospital, Zhejian…

ORCID-Profile: Qi Lu, Min Yue, Yan Li

Förderung

  • MOST | NSFC | NSFC-Zhejiang Joint Fund | | Natural Science Foundation of Zhejiang Province (ZJNSF)
  • MOST | National Natural Science Foundation of China (NSFC)
  • MOST | National Key Research and Development Program of China (NKPs)
  • MOST | NSFC | NSFC-Zhejiang Joint Fund | 浙江省科学技术厅 | Natural Science Foundation of Zhejiang Province

Zitieren

APA

Han, M., Lu, Q., Wang, D., Zhou, K., Jia, C., Teng, L., Hamuti, A., Peng, X., Hu, Y., Li, W., Yue, M., & Li, Y. (2024). Oral co-administration of Lactiplantibacillus plantarum 16 and Lacticaseibacillus rhamnosus P118 improves host defense against influenza A virus infection. Journal of Virology, 98(10). https://doi.org/10.1128/jvi.00950-24

Vancouver

Han M, Lu Q, Wang D, Zhou K, Jia C, Teng L, et al. Oral co-administration of Lactiplantibacillus plantarum 16 and Lacticaseibacillus rhamnosus P118 improves host defense against influenza A virus infection. Journal of Virology. 2024;98(10). doi:10.1128/jvi.00950-24

BibTeX
@article{Han2024,
  author = {Han, Meiqing and Lu, Qi and Wang, Di and Zhou, Kun and Jia, Chenghao and Teng, Lin and Hamuti, Azeguli and Peng, Xianqi and Hu, Yixiang and Li, Weifen and Yue, Min and Li, Yan},
  title = {Oral co-administration of Lactiplantibacillus plantarum 16 and Lacticaseibacillus rhamnosus P118 improves host defense against influenza A virus infection},
  journal = {Journal of Virology},
  year = {2024},
  volume = {98},
  number = {10},
  doi = {10.1128/jvi.00950-24}
}
Kostenlos starten →